Opinionated Science Episode 10: COVID-19 Vaccines: Three Leading Candidates, Assessed

Podcast

Published: July 31, 2020

Opinionated Science Episode 10: COVID-19 Vaccines: Three Leading Candidates, Assessed content piece image

Opinionated Science is Technology Networks’ homemade podcast, where our team of scientists-turned-journalists cut out the chewy jargon and serve up slices of the most fascinating stories from the world of science. Expect a new Opinionated Science every other Friday.

In this episode, the TN team discusses three promising vaccine candidates being developed for COVID-19. We take a deep dive into the data from these vaccine trials to try and work out what successes can be celebrated and what unanswered questions still remain.

Read more from this podcast:

V accine 1: Moderna's mRNA-1273

Vaccine 2: Oxford University's ChAdOx1

Vaccine 3: CanSino Biologics' Adenovirus Type-5

Antigen vs Antibody – What Are the Differences?

A Vaccine 101

Exploring the Drug Development Process

Moderna's COVID-19 Vaccine Shows Positive Interim Results in Phase I Trial

Listen to more Technology Networks podcasts here.

Subscribe to Opinionated Science at your favorite podcast platform:

Listen here on Spotify.

Listen here on Apple Podcasts.

Meet the Authors

Ruairi J Mackenzie

Senior Science Writer

As senior science writer, Ruairi pens and edits scientific news, articles and features, with a focus on the complexities and curiosities of the brain and emerging informatics technologies. Ruairi also drives Technology Networks' search engine optimization (SEO) and editorial AI strategy and created the site’s podcast, Opinionated Science, in 2020. Ruairi has a Master’s degree in Clinical Neurosciences from the University of Cambridge.

Molly Campbell

Senior Science Writer

Molly Campbell is a senior science writer at Technology Networks. She holds a first-class honors degree in neuroscience. In 2021 Molly was shortlisted for the Women in Journalism Georgina Henry Award.

Karen Steward, PhD

Senior Scientific Specialist

Karen Steward holds a PhD in molecular microbiology and evolutionary genetics from the University of Cambridge. She moved into science writing in 2017 after over a decade as a research scientist.